Scott Becker

So today's shout-out goes to everybody in their life as different business people they work with really closely that become important, important colleagues that become invaluable to what they're trying to do in their own business careers, their own professional careers, and whatever they're doing.

To me, Chanel Bunger has moved to the very top of that list as someone that I cannot live without in business, just a wonderful, wonderful leader and person.

So today's shout-out goes both to Chanel.

The advice for everybody is to recognize who those people are in your professional careers and make sure you work closely with them and appreciate them.

I am so thankful for Chanel Bunger.

And so this is today's tribute and shout out to the greatest person I work with today.

Love working with her.

The very best.

Happy birthday to Chanel Bunger, and you are a tremendous, tremendous professional, as good as they come.

Thank you very much.

And thank you all for listening to the Becker Business Podcast, the Becker Private Equity Podcast.

We love what we do.

We hope you enjoy it too.

Thank you very much.

This is Scott Becker with the Becker Business Podcast, the Becker Private Equity Podcast.

Today's discussion is Novo Nordisk and excess profits.

And that's what's happened with Novo Nordisk.

They've cut their expected full-year sales growth to 8% to 14%, down from 20% or so.

Their stock has fallen about 20% today.

It's down more than 20% today.